vs
Alpha Cognition Inc.（ACOG）与Alector, Inc.（ALEC）财务数据对比。点击上方公司名可切换其他公司
Alector, Inc.的季度营收约是Alpha Cognition Inc.的2.2倍（$6.2M vs $2.8M）。Alpha Cognition Inc.净利率更高（-245.5% vs -597.5%，领先352.0%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
ACOG vs ALEC — 直观对比
营收规模更大
ALEC
是对方的2.2倍
$2.8M
净利率更高
ACOG
高出352.0%
-597.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $6.2M |
| 净利润 | $-6.9M | $-37.3M |
| 毛利率 | — | — |
| 营业利润率 | -283.7% | -634.4% |
| 净利率 | -245.5% | -597.5% |
| 营收同比 | — | -88.5% |
| 净利润同比 | — | -1696.9% |
| 每股收益（稀释后） | $-0.10 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACOGALEC
| Q4 25 | $2.8M | $6.2M | ||
| Q3 25 | $2.8M | $3.3M | ||
| Q2 25 | $1.7M | $7.9M | ||
| Q1 25 | $2.9M | $3.7M | ||
| Q4 24 | — | $54.2M | ||
| Q3 24 | — | $15.3M | ||
| Q2 24 | — | $15.1M | ||
| Q1 24 | — | $15.9M |
净利润ACOGALEC
| Q4 25 | $-6.9M | $-37.3M | ||
| Q3 25 | $-1.3M | $-34.7M | ||
| Q2 25 | $-10.5M | $-30.5M | ||
| Q1 25 | $-2.0M | $-40.5M | ||
| Q4 24 | — | $-2.1M | ||
| Q3 24 | — | $-42.2M | ||
| Q2 24 | — | $-38.7M | ||
| Q1 24 | — | $-36.1M |
毛利率ACOGALEC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ACOGALEC
| Q4 25 | -283.7% | -634.4% | ||
| Q3 25 | -187.0% | -1153.6% | ||
| Q2 25 | -346.1% | -433.6% | ||
| Q1 25 | -125.9% | -1216.5% | ||
| Q4 24 | — | -13.4% | ||
| Q3 24 | — | -315.7% | ||
| Q2 24 | — | -302.4% | ||
| Q1 24 | — | -275.0% |
净利率ACOGALEC
| Q4 25 | -245.5% | -597.5% | ||
| Q3 25 | -46.4% | -1063.4% | ||
| Q2 25 | -632.7% | -387.7% | ||
| Q1 25 | -68.5% | -1101.6% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -275.2% | ||
| Q2 24 | — | -256.4% | ||
| Q1 24 | — | -227.0% |
每股收益（稀释后）ACOGALEC
| Q4 25 | $-0.10 | $-0.34 | ||
| Q3 25 | $-0.30 | $-0.34 | ||
| Q2 25 | $-0.65 | $-0.30 | ||
| Q1 25 | $-0.13 | $-0.41 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.43 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.0M | $256.0M |
| 总债务越低越好 | — | $10.0M |
| 股东权益账面价值 | $62.5M | $30.6M |
| 总资产 | $79.7M | $293.2M |
| 负债/权益比越低杠杆越低 | — | 0.33× |
8季度趋势，按日历期对齐
现金及短期投资ACOGALEC
| Q4 25 | $66.0M | $256.0M | ||
| Q3 25 | $35.4M | $291.1M | ||
| Q2 25 | $39.4M | $307.3M | ||
| Q1 25 | $45.5M | $354.6M | ||
| Q4 24 | — | $413.4M | ||
| Q3 24 | — | $457.2M | ||
| Q2 24 | — | $503.3M | ||
| Q1 24 | — | $562.1M |
总债务ACOGALEC
| Q4 25 | — | $10.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACOGALEC
| Q4 25 | $62.5M | $30.6M | ||
| Q3 25 | $33.9M | $57.7M | ||
| Q2 25 | $31.9M | $71.2M | ||
| Q1 25 | $40.8M | $94.6M | ||
| Q4 24 | — | $126.8M | ||
| Q3 24 | — | $118.9M | ||
| Q2 24 | — | $150.6M | ||
| Q1 24 | — | $178.9M |
总资产ACOGALEC
| Q4 25 | $79.7M | $293.2M | ||
| Q3 25 | $46.3M | $335.3M | ||
| Q2 25 | $45.1M | $356.4M | ||
| Q1 25 | $48.6M | $408.3M | ||
| Q4 24 | — | $468.3M | ||
| Q3 24 | — | $516.0M | ||
| Q2 24 | — | $570.7M | ||
| Q1 24 | — | $635.5M |
负债/权益比ACOGALEC
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $-41.7M |
| 自由现金流经营现金流 - 资本支出 | $-7.1M | — |
| 自由现金流率自由现金流/营收 | -252.6% | — |
| 资本支出强度资本支出/营收 | 5.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-20.7M | — |
8季度趋势，按日历期对齐
经营现金流ACOGALEC
| Q4 25 | $-6.9M | $-41.7M | ||
| Q3 25 | $-5.3M | $-32.5M | ||
| Q2 25 | $-6.1M | $-49.0M | ||
| Q1 25 | $-2.0M | $-60.8M | ||
| Q4 24 | — | $-55.0M | ||
| Q3 24 | — | $-50.7M | ||
| Q2 24 | — | $-62.8M | ||
| Q1 24 | — | $-61.3M |
自由现金流ACOGALEC
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-5.4M | $-32.5M | ||
| Q2 25 | $-6.1M | $-49.1M | ||
| Q1 25 | $-2.1M | $-60.8M | ||
| Q4 24 | — | $-55.2M | ||
| Q3 24 | — | $-50.9M | ||
| Q2 24 | — | $-63.1M | ||
| Q1 24 | — | $-61.9M |
自由现金流率ACOGALEC
| Q4 25 | -252.6% | — | ||
| Q3 25 | -188.8% | -997.6% | ||
| Q2 25 | -370.9% | -623.0% | ||
| Q1 25 | -72.0% | -1655.0% | ||
| Q4 24 | — | -101.8% | ||
| Q3 24 | — | -332.1% | ||
| Q2 24 | — | -418.6% | ||
| Q1 24 | — | -389.3% |
资本支出强度ACOGALEC
| Q4 25 | 5.3% | 0.0% | ||
| Q3 25 | 2.6% | 0.3% | ||
| Q2 25 | 0.5% | 0.1% | ||
| Q1 25 | 2.2% | 0.5% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 3.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
